Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion.
Qian, Tianwei
Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion. [electronic resource] - BMJ open 12 2018 - e022700 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
2044-6055
10.1136/bmjopen-2018-022700 doi
Humans
Adrenal Cortex Hormones--adverse effects
Aptamers, Nucleotide--adverse effects
Dexamethasone--adverse effects
Intraocular Pressure--drug effects
Intravitreal Injections
Macular Edema--drug therapy
Randomized Controlled Trials as Topic
Ranibizumab--adverse effects
Receptors, Vascular Endothelial Growth Factor--therapeutic use
Recombinant Fusion Proteins--adverse effects
Retinal Vein Occlusion--complications
Risk Assessment
Treatment Outcome
Triamcinolone--adverse effects
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Network Meta-Analysis
Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion. [electronic resource] - BMJ open 12 2018 - e022700 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
2044-6055
10.1136/bmjopen-2018-022700 doi
Humans
Adrenal Cortex Hormones--adverse effects
Aptamers, Nucleotide--adverse effects
Dexamethasone--adverse effects
Intraocular Pressure--drug effects
Intravitreal Injections
Macular Edema--drug therapy
Randomized Controlled Trials as Topic
Ranibizumab--adverse effects
Receptors, Vascular Endothelial Growth Factor--therapeutic use
Recombinant Fusion Proteins--adverse effects
Retinal Vein Occlusion--complications
Risk Assessment
Treatment Outcome
Triamcinolone--adverse effects
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Network Meta-Analysis